- MicroRNAs for risk assessment and treatment of venous thromboembolism
The challenge
Venous thromboembolism (VTE) is a highly prevalent disease, affecting around 1.1 million individuals in Europe each year, with 540,000 associated deaths. No modifiable risk-factors have been identified yet. The current anti-coagulant treatment is associated with serious bleeding risks. We therefore need to find a drug that prevents VTE without serious side affects.
Our approach
- Specific microRNAs associated with a higher risk of VTE were found
- Targeted intervention of these microRNAs has the potential to effectively prevent VTE
- Treatment of VTE with microRNA therapeutic without bleeding risk
Opportunities for Collaboration
- Searching for a collaborative R&D deal with industrial partner
- Looking for a pharmaceutical partner with the expertise, commitment and financial strength to take it through the clinical phase and into the market.
Results
- Population study
A pilot and a validation study show that specific miRNAs can be potential predictors of VTE and the risk of VTE is highly associated with miRNA level.
- In-vivo mouse model for venous thrombosis
The addition of a specific miRNA show reduction in thrombosis size in an in-vivo mouse model
- Patent application for the technology is filed
Collaboration partners
Contact information
Read about other projects:
Thyroid Assist
– A novel decision support aid tool (DST) for optimal levothyroxinedosage after thyroidectomy About the technology Levothyroxine is a necessary synthetic hormone …
FiRsT – Optical microscope calibration targets
About the technology New and advanced label-free and super resolution microscopes and nanoscopes have emerged, and their characterization is becoming more demanding. …
Nanospacer
– Bringing nanofluidic technology to the people About the technology The Nanospacer is a specially designed microscope coverslip that allows nanoscale particle …
SPICE: Sea sPray ICE prediction model
A tool that predicts ice amount and distribution on marine structures About the technology Due to climate changes the Arctic marine territories …
Novel platform for live-imaging of cells in action
CYMOPLIVE – Cyto-Motility and Cyto-Plasticity in Vitro Live-Cell Assay About the technology Cymoplive is a platform that allows us to study cells …